Open AccessPrompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis
Author(s) -
Derralynn Hughes,
Aleš Linhart,
Andrey Gurevich,
Vasiliki Kalampoki,
Dalia Jazukeviciene,
Sandro Feriozzi
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s313789
Subject(s) - fabry disease , medicine , outcome (game theory) , intensive care medicine , disease , mathematics , mathematical economics
The timing of enzyme replacement therapy initiation in patients with Fabry disease is hypothesized to be critical. In this study, we used Fabry Outcome Survey data to assess the impact of prompt versus delayed initiation of treatment with agalsidase alfa on cardiovascular and renal events in patients with Fabry disease.